AbbVie, Merck, Astra among winners of EU drug recommendations this week
Obesity drugs linked to stalling cancer
- How GLP-1s are more than just weight-loss wonders β but not without risk South China Morning Post —
- Weight-loss drugs from Lilly, Novo linked to stalling cancer: report Seeking Alpha —
- Eli Lillyβs next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —
- New weight-loss drug Retatrutide showing stronger results than current options CBS News —
- Experimental drug yields dramatic weight loss Boston Globe —